Suvretta Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,740
Closed -$1.19M 101
2025
Q1
$1.19M Hold
2,740
0.04% 86
2024
Q4
$1.01M Buy
+2,740
New +$1.15M 0.03% 85
2024
Q3
Sell
-91,442
Closed -$49.5M 102
2024
Q2
$49.5M Buy
91,442
+40,517
+80% +$21.4M 1.82% 16
2024
Q1
$26.4M Sell
50,925
-2,810
-5% -$1.4M 0.98% 35
2023
Q4
$25.3M Buy
53,735
+50,725
+1,685% +$23.5M 1.15% 30
2023
Q3
$1.31M Hold
3,010
0.07% 73
2023
Q2
$1.34M Sell
3,010
-152,311
-98% -$70.3M 0.07% 81
2023
Q1
$71.4M Buy
155,321
+126,350
+436% +$60.1M 3.02% 10
2022
Q4
$14.9M Buy
+28,971
New +$14.7M 0.62% 45
2020
Q1
Sell
-411,750
Closed -$124M 69
2019
Q4
$124M Buy
+411,750
New +$113M 2.83% 16
2019
Q2
Sell
-283,200
Closed -$81.3M 52
2019
Q1
$81.3M Sell
283,200
-18,217
-6% -$5.27M 2.35% 16
2018
Q4
$79.2M Sell
301,417
-496,133
-62% -$136M 4.72% 9
2018
Q3
$219M Buy
+797,550
New +$207M 5.03% 12
2017
Q1
Sell
-244,700
Closed -$35.2M 43
2016
Q4
$35.2M Buy
+244,700
New +$32.8M 0.91% 33

Other funds holding ELV

Suvretta Capital Management's ELV Position: Q2 2025 in Review

Suvretta Capital Management sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 2,740 shares — an estimated $1.19M sold.

Suvretta Capital Management first reported a position in ELV in Q4 2016 and held it in 14 quarters. The position peaked at $219M in Q3 2018. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Suvretta Capital Management reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Suvretta Capital Management sold 2,740 Elevance Health shares in Q2 2025, an estimated $1.19M.
  • Suvretta Capital Management first reported a position in Elevance Health in Q4 2016 and held it in 14 quarters.
  • Suvretta Capital Management's Elevance Health position peaked at $219M in Q3 2018.
  • 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Suvretta Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.